by Grant Title

Title, Institution

Award Cycle, Investigator

Award [sort]

(-) Lobeline: total synthesis and derivitization	2002 (Cycle XI)	$60,000
California Institute of Technology	Jeffrey Bagdanoff B.S.	11DT-0193

11th National Conference on Nicotine Dependence	1998 (Cycle VII)	$12,000
American Society of Addiction Medicine	Lori Karan M.D.	7ST-0198

16S rRNA PhyloChip Analysis of Bacterial Communities in COPD	2008 (Cycle XVII)	$75,000
University of California, San Francisco	Yvonne Huang M.D.	17FT-0040

2nd East West Conference on Tobacco and Alcohol	2005 (Cycle XIV)	$15,000
University of Southern California	Andy Johnson	14ST-0190

2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth	1995 (Cycle IV)	$149,221
The Burnham Institute for Medical Research	Hudson Freeze Ph.D.	4IT-0225

50000 Fold Signal Enhancement for Imaging Vulnerable Plaque	2007 (Cycle XVI)	$213,845
Huntington Medical Research Institute	Pratip Bhattacharya Ph.D.	16KT-0044

A dynamic model of smoking and healthcare expenditures in CA	2000 (Cycle IX)	$595,843
University of California, San Francisco	Wendy Max Ph.D.	9RT-0157

A longitudinal study of smoking transitions in youth	1999 (Cycle VIII)	$577,574
University of California, San Diego	Elizabeth Gilpin M.S.	8RT-0086

A Methodological Multi-Ethnic Study of Smoking Initiation	1995 (Cycle IV)	$260,978
University of California, Los Angeles	Celia Kaplan DrPH	4RT-0257

A mindfulness-based approach to relapse prevention	2005 (Cycle XIV)	$134,325
California Pacific Medical Center Research Institute	Cassandra Vieten Ph.D.	14IT-0178

A model system for smoking-related damage to proteins	1999 (Cycle VIII)	$75,375
J. David Gladstone Institutes	Johan Bjorkegren M.D., Ph.D.	8FT-0022

A New Approach for Studying the Mechanism of Squamous Metapl	1995 (Cycle IV)	$75,000
University of California, Los Angeles	Sanford Barsky M.D.	4IT-0328

A new molecular approach for predicting lung cancer	2000 (Cycle IX)	$75,000
University of California, Irvine	Ram Kumar Sindhu Ph.D.	9IT-0121

A novel approach to prevent in utero nicotine lung injury	2005 (Cycle XIV)	$597,916
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Virender Rehan M.D.	14RT-0073

A Novel Approach to Prevent in Utero Nicotine Lung Injury	2008 (Cycle XVII)	$564,957
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Virender Rehan M.D.	17RT-0170

A novel FMRI smoking craving and reward paradigm	2003 (Cycle XII)	$96,949
University of California, Los Angeles	John Monterosso Ph.D.	12IT-0198

A novel lung tumor suppressor	1997 (Cycle VI)	$144,788
The Burnham Institute for Medical Research	Steven Frisch Ph.D.	6IT-0128

A novel therapeutic target for stroke	1997 (Cycle VI)	$72,310
The Burnham Institute for Medical Research	Li-Tao Zhong M.D., Ph.D.	6FT-0157

A novel total synthesis of brazilin and brazilide A	2005 (Cycle XIV)	$59,191
University of California, Santa Barbara	Yaodong Huang M.S.	14DT-0130

A novel, 3-dimensional approach to non-invasive diagnostics	2005 (Cycle XIV)	$99,000
University of California, Irvine	Petra Wilder-Smith D.D.S., Ph.D.	14IT-0097

A retroviral link to human tobacco-related lung cancer?	1999 (Cycle VIII)	$74,500
University of California, Los Angeles	Sanford Barsky M.D.	8IT-0046

A Smokeless Tobacco Cessation Program: High School Athletes	1995 (Cycle IV)	$533,923
University of California, San Francisco	Margaret Walsh MS, EdD	4RT-0068

A stage-based scheduled smoking intervention for Chinese	2005 (Cycle XIV)	$554,500
University of California, San Francisco	Janice Tsoh Ph.D.	14RT-0160H

A study of Bax, a gene involved in killing tumor cells	1998 (Cycle VII)	$75,060
The Burnham Institute for Medical Research	Shahrzad Nouraini Ph.D.	7FT-0100

A web-based support community as a tool for ST cessation	2003 (Cycle XII)	$100,000
University of California, San Francisco	Margaret Walsh MS, EdD	12IT-0169

Acculturation & cigarette smoking among Asian-Americans	1997 (Cycle VI)	$244,715
University of Southern California	Xinguang Chen Ph.D.	6KT-0191

Acculturation, media, peers, parents and adolescent smoking	1998 (Cycle VII)	$213,511
University of Southern California	Jennifer Unger Ph.D.	7PT-7004H

Activation and detoxification of lung cancer carcinogens	2006 (Cycle XV)	$420,000
University of California, San Diego	Robert Tukey Ph.D.	15RT-0251

Activation of Bnip3 in tobacco-induced heart disease	2005 (Cycle XIV)	$134,074
Scripps Research Institute	Asa Gustafsson Ph.D.	14KT-0109

Activation of Bnip3 in tobacco-induced heart disease	2005 (Cycle XIV)	$155,791
San Diego State University Research Foundation	Asa Gustafsson Ph.D.	14KT-0109A

Activation of NF-kB by cigarette smoke	1999 (Cycle VIII)	$224,217
University of California, Davis	Richart Harper M.D.	8KT-0092

Ad and Movie Imagery and Teen's Perceptions About Smokers	1995 (Cycle IV)	$190,616
University of California, Irvine	Cornelia Pechmann Ph.D.	4RT-0082

Addressing Substance Abusers Who Also Smoke	1994 (Cycle III)	$270,931
Northern California Institute for Research & Education	Karen Sees D.O.	3KT-0121

Adolescent susceptibility to tobacco: a panel analysis	2001 (Cycle X)	$495,433
University of California, Irvine	Larry Jamner Ph.D.	10RT-0255

Adolescent Susceptibility to Tobacco: A Panel Analysis	1997 (Cycle VI)	$456,076
University of California, Irvine	Larry Jamner Ph.D.	6PT-3003H

African American church role in tobacco norm change	2005 (Cycle XIV)	$115,098
Health Education Council	Ayanna Kiburi MPH	14IT-0188

African Americans and Mentholated Cigarettes	1999 (Cycle VIII)	$417,968
Charles R. Drew University of Medicine & Science	Bruce Allen DrPH	8RT-0091H

African Americans: NRT or Alternative Medicine for Cessation	2006 (Cycle XV)	$285,000
University of California, San Francisco	Valerie Yerger ND, MA	15KT-0038H

Aggression and Nicotine	1997 (Cycle VI)	$230,326
University of California, Irvine	Larry Jamner Ph.D.	6RT-0154

Airway transcriptome changes in smokers	2004 (Cycle XIII)	$99,500
University of California, San Francisco	John Fahy M.D.	13IT-0097

ALAC 2003 Annual Conference	2003 (Cycle XII)	$5,000
American Lung Association of California	Steve O'Kane	12ST-0264

ALAC Annual Conference	2005 (Cycle XIV)	$2,500
American Lung Association of California	Lynn Devine	14ST-0192

ALAC Annual Conference	2006 (Cycle XV)	$5,000
American Lung Association of California	Kerlyn Chatelain-Graham	15ST-0258

ALAC Annual Conference	2007 (Cycle XVI)	$5,000
American Lung Association of California	Laura Keegan	16ST-0217

ALAC Conference	2004 (Cycle XIII)	$5,000
American Lung Association of California	Laura Keegan	13ST-0175

Allocation of Health Care to Smokers: Practice and Ethics	1998 (Cycle VII)	$113,598
Stanford University	Thomas Raffin M.D.	7IT-0129

Allosteric Protein Kinase Modulators via Disulfide Trapping	2008 (Cycle XVII)	$75,000
University of California, San Francisco	Jack Sadowsky Ph.D.	17FT-0042

*Alpha4 Nicotinic Receptor in Dopaminergic System**	2007 (Cycle XVI)	$75,000
California Institute of Technology	Cheng Xiao Ph.D.	16FT-0066

Alterations in gene expression after tobacco smoke exposure	1997 (Cycle VI)	$216,612
University of California, Davis	Ken Yoneda M.D.	6KT-0016

Alternative sources of ETS exposure in infants	1998 (Cycle VII)	$109,687
San Diego State University Research Foundation	Georg Matt Ph.D.	7IT-0087

An athletic trainer mediated spit tobacco cessation program	1998 (Cycle VII)	$490,546
University of California, San Francisco	Margaret Walsh MS, EdD	7RT-0058

An economic analysis of factors influencing teen smoking	1998 (Cycle VII)	$221,497
University of California, San Diego	Sherry Emery MBA, Ph.D.	7KT-0193

An RNA biomarker for tobacco smoke toxicity	1999 (Cycle VIII)	$51,751
University of California, Davis	Richard Kimura	8DT-0174

Anabolic therapies for muscle dysfunction in women with COPD	2001 (Cycle X)	$632,153
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Richard Casaburi M.D., Ph.D.	10RT-0046

Analysis of a candidate lung tumor suppressor gene at 3p21.3	2000 (Cycle IX)	$111,910
Beckman Research Institute of the City of Hope	Gerd Pfeifer Ph.D.	9RT-0175

Analysis of a lung tumor supressor gene at 3p21.3	2001 (Cycle X)	$249,438
Beckman Research Institute of the City of Hope	Gerd Pfeifer Ph.D.	10RT-0016

Analysis of a nicotine-related receptor binding site	1997 (Cycle VI)	$69,218
University of California, San Francisco	Laura England Ph.D.	6FT-0103

Analysis of California adolescent tobacco data	2001 (Cycle X)	$475,742
University of California, Los Angeles	William McCarthy Ph.D.	10RT-0333

Analysis of the Hippo pathway in lung cancer	2008 (Cycle XVII)	$654,999
Beckman Research Institute of the City of Hope	Gerd Pfeifer Ph.D.	17RT-0116

Analysis of tobacco industry documents on scientific researc	2000 (Cycle IX)	$442,646
University of California, San Francisco	Lisa Bero Ph.D.	9RT-0193

Antiatherogenic helical segments of apo A-I	2004 (Cycle XIII)	$141,230
Lawrence Berkeley National Laboratory	John Bielicki Ph.D.	13IT-0025

Antioxidants, cigarette smoking and atherosclerosis	1998 (Cycle VII)	$730,640
University of Southern California	James Dwyer Ph.D.	7RT-0034

Antismoking slides in movie Theaters: A Naturalistic Eval	2000 (Cycle IX)	$10,000
University of California, Irvine	Cornelia Pechmann Ph.D.	9ST-0244

Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing	1997 (Cycle VI)	$446,947
University of California, Los Angeles	Barbara Berman Ph.D.	6RT-0047

ApoE isoforms, fatty acid metabolism and atherosclerosis	2001 (Cycle X)	$691,616
J. David Gladstone Institutes	Robert Pitas Ph.D.	10RT-0313

ApoE related effect of smoking in cardiovascular disease	2008 (Cycle XVII)	$630,561
Children's Hospital Oakland Research Institute	Vasanthy Narayanaswami Ph.D.	17RT-0165

Apolipoprotein E: remnant metabolism and atherogenesis	1999 (Cycle VIII)	$793,474
J. David Gladstone Institutes	Yadong Huang M.D., Ph.D.	8RT-0130

Ascertainment of environmental tobacco exposure in pregnancy	1999 (Cycle VIII)	$2,053,747
Sequoia Foundation	Martin Kharrazi Ph.D.	8RT-0115

Asian American and Pacific Islander (AAPI) Sci. Conf./Wkshp.	2007 (Cycle XVI)	$5,000
University of California, Los Angeles	Yih-Ing Hser Ph.D.	16ST-0214

Assessing nicotine relapse in a mouse model	2001 (Cycle X)	$183,804
SRI International	Taline Khroyan Ph.D.	10KT-0007

Association of Outlet Density with Smoking and Pack Price	2008 (Cycle XVII)	$516,285
Stanford University	Lisa Henriksen Ph.D.	17RT-0152

Asthma, gender, and ETS: pathogenic synergy	2005 (Cycle XIV)	$98,908
University of California, Davis	Laurel Gershwin D.V.M., Ph.D.	14IT-0081

BAG-1, a unique gene involved in smoking-associated cancers	1998 (Cycle VII)	$75,060
The Burnham Institute for Medical Research	Zhihua Xie Ph.D.	7FT-0092

Banning Butts: The Environmental Case	2008 (Cycle XVII)	$99,500
University of California, San Francisco	Thomas Novotny M.D., MPH	17IT-0014

Bayview-Hunters Point partnership toward smoking cessation	2002 (Cycle XI)	$75,000
University of California, San Francisco	Carol McGruder B.A.	11BT-1701

Bayview-Hunters Point partnership toward smoking cessation	2002 (Cycle XI)	$75,000
University of California, San Francisco	Ruth Malone Ph.D., R.N.	11BT-1701

Behavioral effects of neonatal nicotine exposure	2000 (Cycle IX)	$624,780
San Diego State University Research Foundation	Edward Riley Ph.D.	9RT-0012

Behavioral epidemiology of tobacco use among gay men	1998 (Cycle VII)	$626,433
University of California, San Francisco	Greg Greenwood Ph.D.	7RT-0013

Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro	1995 (Cycle IV)	$321,199
University of California, San Diego	Hyam Leffert M.D.	4RT-0076

Bioactive lipids in tobacco related lung cancers	1997 (Cycle VI)	$74,496
University of California, San Diego	Jerold Chun M.D., Ph.D.	6IT-0375

Birth defects, smoking and host susceptibility	2003 (Cycle XII)	$466,200
March of Dimes Birth Defects Foundation	Suzan Carmichael Ph.D.	12RT-0098

Bispecific molecular therapy of small cell lung cancer	2001 (Cycle X)	$434,805
University of California, San Diego	Edward Ball M.D.	10RT-0064

Boosting the immune response against lung cancer	1998 (Cycle VII)	$70,000
University of California, Los Angeles	Marina Stolina Ph.D.	7FT-0035

Brachial Vasoreactivity in Young Adult Smokers	1997 (Cycle VI)	$332,294
Osteoporosis Medical Center	Jacques Barth M.D., Ph.D.	6RT-0053

Brain adaptations to chronic nicotine expsoure	1997 (Cycle VI)	$402,111
University of California, Irvine	Frances Leslie Ph.D.	6RT-0416

Brain imaging in nicotine addiction	2002 (Cycle XI)	$419,881
University of California, Los Angeles	Desmond Smith Ph.D.	11RT-0172

Brain metabolic changes with cigarette craving	1998 (Cycle VII)	$250,850
Brentwood Biomedical Research Institute	Arthur Brody M.D.	7KT-0098

Brain nAChR Occupancy: Effect of Secondhand Smoke	2007 (Cycle XVI)	$623,841
Brentwood Biomedical Research Institute	Arthur Brody M.D.	16RT-0098

Brain wave assessment of tobacco cessation readiness	1997 (Cycle VI)	$115,487
Scripps Research Institute	Aaron Ilan Ph.D.	6KT-0312

Bupropion and nicotine dependence: behavior & neurochemisty	2005 (Cycle XIV)	$37,500
Scripps Research Institute	Neil Paterson B.Sc., MBCh.B.	14FT-0056

Bupropion and nicotine dependence: behavior & neurochemisty	2005 (Cycle XIV)	$37,000
University of California, San Diego	Neil Paterson B.Sc., MBCh.B.	14FT-0056A

Bupropion for hospital-based smoking cessation	2003 (Cycle XII)	$478,065
University of California, San Francisco	Joel Simon M.D., M.P.H.	12RT-0148

Bupropion for smoking cessation	1998 (Cycle VII)	$471,154
University of California, San Francisco	Joel Simon M.D., M.P.H.	7RT-0033

California AB13 compliance and ethnicity in urban bars	2003 (Cycle XII)	$769,266
Pacific Institute for Research and Evaluation	Roland Moore BA, MA, Ph.D.	12RT-0116

California pharm-assists for smoking cessation	1999 (Cycle VIII)	$124,689
SRI International	Karen Hudmon Dr.P.H., R.P.H., M.S.	8BT-2301

California pharm-assists for smoking cessation	1999 (Cycle VIII)	$124,689
SRI International	Marilyn Shreve R.Ph.	8BT-2301

Calorigenic and Atherogenic Effects of Smoking and Nicotine	1995 (Cycle IV)	$357,492
University of California, San Francisco	Marc Hellerstein M.D., Ph.D.	4RT-0233

Cambodian research initiative	2003 (Cycle XII)	$106,456
California State University, Long Beach Foundation	Robert Friis Ph.D.	12BT-2201

Cambodian research initiative	2003 (Cycle XII)	$106,456
California State University, Long Beach Foundation	Him Chhim MS, MPA	12BT-2201

Carbon monoxide and the brain growth spurt	1998 (Cycle VII)	$464,268
University of California, Los Angeles	John Edmond Ph.D.	7RT-0039

Carbon monoxide as a modulator of myocardial function	1999 (Cycle VIII)	$225,000
University of California, Davis	Ulrike Kreutzer Ph.D.	8KT-0042

Cardiac ion channels and tobacco-related disease	2002 (Cycle XI)	$389,983
University of California, Santa Barbara	Carol Vandenberg Ph.D.	11RT-0114

Cardiovascular responses through spinal nicotinic receptors	2001 (Cycle X)	$448,941
University of California, San Diego	Palmer Taylor Ph.D.	10RT-0107

Cardiovascular responses to nicotine	1997 (Cycle VI)	$430,843
University of California, San Diego	Palmer Taylor Ph.D.	6RT-0009

Case studies of indoor air regulations: role of research	1997 (Cycle VI)	$292,210
University of California, San Francisco	Lisa Bero Ph.D.	6RT-0025

Cell adhesion at nicotinic synapses	2005 (Cycle XIV)	$59,454
University of California, San Diego	Gallen Triana-Balzer B.A.	14DT-0092

Cell-cell interact reg distrib of nic receptrs on neurons	2000 (Cycle IX)	$29,754
University of California, San Diego	Sergio Kaiser	9FT-0021

Cellular Defects in Lung caused by Tobacco Smoke	1995 (Cycle IV)	$319,013
University of California, San Francisco	Alan Verkman M.D., Ph.D.	4RT-0072

cGMP regulation of vascular smooth muscle differentiation	2005 (Cycle XIV)	$403,818
University of California, San Diego	Renate Pilz M.D.	14RT-0020

Chemical synthesis of communesin B, a novel antineoplastic	2005 (Cycle XIV)	$74,403
California Institute of Technology	Shyam Krishnan Ph.D.	14FT-0002

Chemokine-based therapy for lung cancer	2001 (Cycle X)	$416,940
University of California, Los Angeles	Sherven Sharma Ph.D.	10RT-0053

Chemopreventive strategies against lung cancer recurrence	2000 (Cycle IX)	$75,000
University of California, Los Angeles	Jenny Mao M.D.	9IT-0023

Chemotherapeutic inhibition of polysialic acid biosynthesis	2003 (Cycle XII)	$420,781
University of California, Davis	Jacquelyn Gervay-Hague Ph.D.	12RT-0254H

Cholesterol metabolism and atherosclerosis	1997 (Cycle VI)	$74,500
University of California, San Diego	Oswald Quehenberger Ph.D.	6IT-0133

Chromatin Remodeling in Glucocorticoid Resistance of COPD	2008 (Cycle XVII)	$60,000
University of California, San Francisco	Karin Buser B.S.	17DT-0177

Chronic bronchitis: pathology of mucin gene expression	2000 (Cycle IX)	$329,481
University of California, Davis	Walter Finkbeiner M.D., Ph.D.	9RT-0214

Chronic bronchitis: pathology of mucin gene expression	2000 (Cycle IX)	$147,758
University of California, San Francisco	Walter Finkbeiner M.D., Ph.D.	9RT-0214A

Chronic CO exposure impairs the developing auditory system	2004 (Cycle XIII)	$75,000
University of California, Los Angeles	Douglas Webber Ph.D.	13FT-0150

Chronic nicotine treatment in primates; role of a6b2 nAChRs	2008 (Cycle XVII)	$577,128
The Parkinson's Institute	Maryka Quik Ph.D.	17RT-0119

Cigar smoking among young adults: formative research	1997 (Cycle VI)	$292,920
California State University, Long Beach Foundation	Fen Rhodes Ph.D.	6RT-0426

Cigar use prevalence: social and media determinants	1997 (Cycle VI)	$318,750
San Diego State University Research Foundation	Joachim Reimann Ph.D.	6KT-0117

Cigarette smoke alters lipoprotein & artery wall interaction	1997 (Cycle VI)	$472,876
University of California, Los Angeles	Alan Fogelman M.D.	6RT-0006

Cigarette smoke effects on cells crucial for wound healing	2001 (Cycle X)	$74,500
University of California, Riverside	Manuela Martins-Green Ph.D.	10IT-0170

Cigarette smoke effects on human vascular endothelial genes	1998 (Cycle VII)	$75,000
University of California, Riverside	Craig Byus Ph.D.	7IT-0173

Cigarette smoke injures lung epithelium by activating nSMase	2008 (Cycle XVII)	$394,380
University of California, Davis	Tzipora Goldkorn BSc, MSc, Ph.D.	17RT-0131

Cigarette smoke, MCP-1 expression in vivo and atherogenesis	2002 (Cycle XI)	$50,418
University of California, Riverside	Lina Seang Wong B.S.	11DT-0244

Cigarette Smoking and Stress-Coping among Latino Youth	2008 (Cycle XVII)	$60,000
University of Southern California	Rachel Grana M.P.H.	17DT-0190

Cigarette smoking in HIV-positive populations	2000 (Cycle IX)	$74,882
University of California, San Francisco	Gary Humfleet Ph.D.	9IT-0234

Classroom animation tobacco awareness program effectiveness	2004 (Cycle XIII)	$558,761
WestEd	Barbara Dietsch Ph.D.	13HT-3201

Classroom animation tobacco awareness program effectiveness	2004 (Cycle XIII)	$558,761
WestEd	Diane Schwartz M.A.	13HT-3201

Clearing the Air: An Institute for Policy Advocacy, IV	2007 (Cycle XVI)	$5,000
American Nonsmokers' Rights Foundation	Cynthia Hallett MPH	16ST-0215

Clearing the Air: An Institute for Policy Advocacy, V	2007 (Cycle XVI)	$5,000
American Nonsmokers' Rights Foundation	Cynthia Hallett MPH	16ST-0221

Clinical Pharmacology of Tobacco Alkaloids	2006 (Cycle XV)	$508,848
University of California, San Francisco	Peyton Jacob Ph.D.	15RT-0181

Clinical pharmacology of tobacco alkaloids	2001 (Cycle X)	$373,408
University of California, San Francisco	Peyton Jacob Ph.D.	10RT-0215

Clinical Pharmacology of Tobacco Alkaloids	1995 (Cycle IV)	$393,855
University of California, San Francisco	Peyton Jacob Ph.D.	4RT-0023

Clinical pharmacology of tobacco alkaloids	1998 (Cycle VII)	$439,882
University of California, San Francisco	Peyton Jacob Ph.D.	7RT-0104

Cloning & Expression of the Apo-B mRNA Editing Factor	1994 (Cycle III)	$254,743
J. David Gladstone Institutes	Thomas Innerarity Ph.D.	3RT-0404

Cloning of a Lung Tumor Transport Gene for Drug Development	1995 (Cycle IV)	$104,966
University of California, San Diego	Michael Kelner M.D., M.S.	4IT-0194

Cognitive effects of gestational nicotine	2004 (Cycle XIII)	$60,000
University of California, Irvine	Shahrdad Lotfipour Ph.D.	13DT-0033

Community and Family Context of Teen Smoking	2008 (Cycle XVII)	$270,000
University of California, Los Angeles	Ritesh Mistry Ph.D. M.P.A.	17KT-0030

Comprehensive evaluation of the ischemic leg	2000 (Cycle IX)	$672,390
Stanford University	Dwight Nishimura Ph.D.	9RT-0024

Comprehensive Tobacco Policy Model	1997 (Cycle VI)	$439,963
University of California, Irvine	Tammy Tengs Sc.D.	6PT-3005

Computer Simulation as a Tool for Reducing SHS Exposure	2007 (Cycle XVI)	$118,418
Education Training and Research Associates, Inc.	Neil Klepeis	16IT-0209

Conformationally constrained nicotine vaccines	2005 (Cycle XIV)	$778,921
Scripps Research Institute	Kim Janda Ph.D.	14RT-0110

Context & consequenes of smoking in a blue-collar cohort	2005 (Cycle XIV)	$426,555
Pacific Institute for Research and Evaluation	Carol Cunradi Ph.D., M.P.H.	14RT-0116

Contributions of CNRs to nicotinic signaling	2001 (Cycle X)	$70,000
University of California, San Diego	Martina Blank Ph.D.	10FT-0235

Control of Mucociliary Clearance in the Respiratory Tract	1995 (Cycle IV)	$276,780
University of California, Los Angeles	Ellen Dirksen Ph.D.	4RT-0079

Controlled study of withdrawal symptoms in teen smokers	2003 (Cycle XII)	$499,890
Stanford University	Joel Killen Ph.D.	12RT-0141

COPD: oxygen transport and metabolism in skeletal muscle	2001 (Cycle X)	$224,500
University of California, San Diego	Luke Haseler Ph.D.	10KT-0335

Co-regulator mechanisms in lung cancer	1999 (Cycle VIII)	$38,267
University of California, San Diego	Bogi Andersen M.D.	8IT-0039

Corporate strategies: design, conduct, publication of resrch	2004 (Cycle XIII)	$407,567
University of California, San Francisco	Lisa Bero Ph.D.	13RT-0108H

Correlates of cigarette craving in acute nicotine withdrawal	2003 (Cycle XII)	$17,000
University of California, Los Angeles	Murray Jarvik M.D., Ph.D.	12RT-0132

Correlates of cigarette craving in acute nicotine withdrawal	2003 (Cycle XII)	$517,818
Brentwood Biomedical Research Institute	Richard Olmstead Ph.D.	12RT-0132AH

Cotinine Metabolism in Infants and Children	2006 (Cycle XV)	$509,473
University of California, San Francisco	Neal Benowitz M.D.	15RT-0229

COX-2 regulation of vaccination responses in lung cancer	2004 (Cycle XIII)	$379,362
University of California, Los Angeles	Steven Dubinett M.D.	13RT-0031

COX-2-dependent modulation of survivin in lung cancer	2003 (Cycle XII)	$69,500
University of California, Los Angeles	Kostyantyn Krysan Ph.D.	12FT-0061

CSF biomarkers of brain metastases from lung cancer	2003 (Cycle XII)	$100,000
University of California, San Francisco	James Rubenstein M.D., Ph.D.	12IT-0246

CT imaging to assist diagnosis of solitary pulmonary nodules	2000 (Cycle IX)	$59,002
University of California, Los Angeles	Michael McNitt-Gray Ph.D.	9RT-0065

Culture and Tobacco Among American Indian Adolescents	2006 (Cycle XV)	$827,725
University of Southern California	Jennifer Unger Ph.D.	15RT-0111

Current legal issues in tobacco	1997 (Cycle VI)	$34,746
University of California, San Francisco	Brion Fox S.M., J.D.	6FT-0105

Curriculum for treating nicotine dependence in psychiatry	2004 (Cycle XIII)	$269,243
University of California, San Francisco	Judith Prochaska Ph.D., M.P.H.	13KT-0152

Cytokine gene-modified dendritic cells for lung cancer	2000 (Cycle IX)	$590,523
University of California, Los Angeles	Steven Dubinett M.D.	9RT-0118

Defining mutagenesis pathways in tobacco-related cancer	2005 (Cycle XIV)	$58,993
Scripps Research Institute	Bryan O'Neill BA Chemistry	14DT-0137

Deposition of inhaled carcinogens in ETS	2001 (Cycle X)	$210,446
University of California, Irvine	Michael Oldham M.S.	10KT-0003

Depression as a predictor of smoking treatment outcome	2001 (Cycle X)	$52,467
University of California, San Francisco	G. Scott Acton Ph.D.	10FT-0248

Detection of occult metastases in patients with lung cancer	1999 (Cycle VIII)	$723,842
University of Southern California	Richard Cote M.D.	8RT-0061

Determinants of smoking among gay & lesbian youth	2000 (Cycle IX)	$509,771
University of California, San Francisco	Jay Paul Ph.D.	9RT-0218

Determinants of Smoking Prevalence among Cambodian Americans	2007 (Cycle XVI)	$693,630
California State University, Long Beach Foundation	Kimthai Kuoch	16AT-1300H

Determinants of Smoking Prevalence among Cambodian Americans	2007 (Cycle XVI)	$693,630
California State University, Long Beach Foundation	Robert Friis Ph.D.	16AT-1300H

Determinants of Susceptibility to Oxidized Lipoproteins	1995 (Cycle IV)	$495,384
University of California, Los Angeles	Alan Fogelman M.D.	4RT-0074

Determining how cholesterol-rich Lp(a) causes heart disease	1998 (Cycle VII)	$797,092
J. David Gladstone Institutes	Robert Pitas Ph.D.	7RT-0018

Developing new vaccines for lung cancer	1998 (Cycle VII)	$398,511
University of California, Los Angeles	Michael Roth M.D.	7RT-0040

Developing policy to reverse cigar trend: roles of media	1997 (Cycle VI)	$249,785
University of California, San Francisco	Lisa Bero Ph.D.	6RT-0026

Developing treatments that lower blood cholesterol levels	1997 (Cycle VI)	$746,536
Scripps Research Institute	Linda Curtiss Ph.D.	6RT-0034

Development of a blood test for pancreatic cancer	1997 (Cycle VI)	$308,819
Stanford University	Anson Lowe M.D.	6RT-0439

Development of a new device to measure ambulatory smoking	2000 (Cycle IX)	$72,238
University of California, Los Angeles	Richard Olmstead Ph.D.	9IT-0035

Development of Fluorescent Probes for Sensing DNA Mismatches	2006 (Cycle XV)	$65,369
California Institute of Technology	Mi Hee Lim Ph.D.	15FT-0166

Development of nicotine withdrawal measures	2005 (Cycle XIV)	$50,956
University of California, San Diego	Svetlana Semenova Ph.D.	14IT-0053A

Development of nicotine withdrawal measures	2005 (Cycle XIV)	$91,173
Scripps Research Institute	Svetlana Semenova Ph.D.	14IT-0053

Developmental Relationship between NK and T-Cell Lineages	1995 (Cycle IV)	$434,126
California Institute of Technology	Ellen Rothenberg Ph.D.	4RT-0264

Diabetes & tobacco exposure in So CA American Indians	2005 (Cycle XIV)	$468,390
University of California, San Diego	Deborah Morton Ph.D.	14RT-0024H

Diagnostic tools of HDL damage by tobacco smoke	2000 (Cycle IX)	$113,878
Lawrence Berkeley National Laboratory	John Bielicki Ph.D.	9IT-0083

Diaphragm adaptations following treatment for emphysema	1997 (Cycle VI)	$469,400
Cedars-Sinai Medical Center	Michael Lewis M.D.	6RT-0144

Dietary fat and ETS effects on lung epithelial biology	2003 (Cycle XII)	$99,827
University of California, Davis	Laura Van Winkle Ph.D.	12IT-0191

Discovery of serum markers of lung cancer	1998 (Cycle VII)	$120,300
Cedars-Sinai Medical Center	Phillip Koeffler M.D.	7IT-0066

Disproportionate cost of smoking for communities of color	2004 (Cycle XIII)	$278,980
University of California, San Francisco	Wendy Max Ph.D.	13RT-0030

Dissecting signaling pathways to test cancer-killing agents	1998 (Cycle VII)	$69,694
University of California, San Diego	Yi Chen Ph.D.	7FT-0150

Dissemination of a smoking cessation program for in patients	1999 (Cycle VIII)	$710,621
Stanford University	C. Barr Taylor M.D.	8RT-0031

Dissemination of the Rx for Change in Psychiatry Curriculum	2008 (Cycle XVII)	$439,283
University of California, San Francisco	Judith Prochaska Ph.D., M.P.H.	17RT-0077

Dissuading at-risk youth from smoking via mass media	2000 (Cycle IX)	$610,340
University of California, Irvine	Cornelia Pechmann Ph.D.	9RT-0209H

DNA replication, regulation of the cell cycle, and cancer	2000 (Cycle IX)	$571,742
California Institute of Technology	Judith Campbell Ph.D.	9RT-0179

Do receptors mediate the effects of nicotine on anxiety?	2005 (Cycle XIV)	$291,060
Salk Institute for Biological Studies	Tammy Booker Ph.D.	14KT-0113

Does nicotine alter intercellular communication pathways?	1997 (Cycle VI)	$68,864
University of California, San Diego	Ching-Yi Chen Ph.D.	6FT-0135

Does nicotine exposure inhibit convective drug delivery ?	2007 (Cycle XVI)	$189,400
La Jolla Bioengineering Institute	Ugur Ozerdem M.D.	16IT-0212A

Does nicotine increase sprouting of pericyte tubes?	2004 (Cycle XIII)	$207,300
La Jolla Institute for Molecular Medicine	Ugur Ozerdem M.D.	13IT-0067

Does nicotine inhibit anticancer activities of Vitamin A?	1997 (Cycle VI)	$788,808
The Burnham Institute for Medical Research	Xiao-Kun Zhang Ph.D.	6RT-0168

Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma	1994 (Cycle III)	$389,719
University of California, San Francisco	Rik Derynck Ph.D.	3RT-0104

Does tobacco exposure delay conception?	2003 (Cycle XII)	$447,845
Sequoia Foundation	Michelle Pearl Ph.D.	12RT-0202

Dynamics of state tobacco control making	1999 (Cycle VIII)	$70,000
University of California, San Francisco	Michael Givel Ph.D.	8FT-0095

Dysregulation of VSMC signaling induced by nicotine	2001 (Cycle X)	$683,510
Stanford University	Philip Tsao Ph.D.	10RT-0298

Early detection of oral cancer	1998 (Cycle VII)	$74,901
University of California, Irvine	Petra Wilder-Smith D.D.S., Ph.D.	7IT-0192

Economic Analysis of Smoking Cessation Therapies	1999 (Cycle VIII)	$270,206
University of California, San Francisco	James Milton Lightwood Ph.D.	8RT-0007

Economic Effects of California Cigarette Tax	1998 (Cycle VII)	$98,528
University of California, Berkeley	Teh-Wei Hu Ph.D.	7ST-0201

Economic Impact of Secondhand Smoke for Communities of Color	2007 (Cycle XVI)	$216,038
University of California, San Francisco	Wendy Max Ph.D.	16RT-0075

Effect of cigarette smoke and nicotine on taste processing	2002 (Cycle XI)	$70,000
University of California, Davis	Christopher Simons Ph.D.	11FT-0101

Effect of cigarette smoking on pulmonary metastasis	2001 (Cycle X)	$36,236
University of California, Davis	Susan Murin M.D.	10IT-0264

Effect of estrogen on ETS-induced glyco-oxidation	2000 (Cycle IX)	$24,692
University of California, Davis	Jeana LeAnn Benton B.S.	9DT-0130

Effect of maternal smoking on early human development	2003 (Cycle XII)	$505,975
University of California, San Francisco	Susan Fisher Ph.D.	12RT-0059

Effect of Maternal Smoking on Early Human Development	2006 (Cycle XV)	$489,025
University of California, San Francisco	Susan Fisher Ph.D.	15RT-0037

Effect of maternal smoking on human placental development	1997 (Cycle VI)	$450,000
University of California, San Francisco	Susan Fisher Ph.D.	6RT-0304

Effect of maternal smoking on human placental development	2000 (Cycle IX)	$515,124
University of California, San Francisco	Susan Fisher Ph.D.	9RT-0112

Effect of nicotine on bone marrow cells	2001 (Cycle X)	$520,381
La Jolla Institute for Molecular Medicine	Sophia Khaldoyanidi M.D., Ph.D.	10KT-0036H

Effect of nicotine on fetal hemopoietic stem cell migration	2002 (Cycle XI)	$152,352
La Jolla Institute for Molecular Medicine	Sophia Khaldoyanidi M.D., Ph.D.	11IT-0020

Effect of Oxidation on Rate of ApoA-I - HDL Exchange	2007 (Cycle XVI)	$75,000
Children's Hospital Oakland Research Institute	Giorgio Cavigiolio Ph.D.	16FT-0054

Effect of PDGF inhibition on angiogenesis in lung cancer	2005 (Cycle XIV)	$74,500
University of California, San Francisco	Beverly Falcon Ph.D.	14FT-0152

Effect of secondhand smoke on pulmonary t cell recruitment	1999 (Cycle VIII)	$69,094
University of California, Davis	Lisa Miller Ph.D.	8IT-0054

Effect of sidestream smoke on lung injury and repair	1997 (Cycle VI)	$214,070
University of California, Davis	Laura Van Winkle Ph.D.	6KT-0306

Effect of Sidestream Tobacco Smoke on Parkin Null Mice	2006 (Cycle XV)	$48,256
University of California, Los Angeles	Owen Kelly Ph.D.	15FT-0068

Effect of smoke and gender on bronchiolar injury and repair	2002 (Cycle XI)	$413,288
University of California, Davis	Laura Van Winkle Ph.D.	11RT-0258

Effect of smoke and gender on bronchiolar injury and repair	2005 (Cycle XIV)	$418,207
University of California, Davis	Laura Van Winkle Ph.D.	14RT-0132

Effect of Smoking on Success Rate of In Vitro Fertilization	1995 (Cycle IV)	$449,805
University of California, San Diego	Hillary Klonoff-Cohen Ph.D.	4RT-0032

Effect of Tobacco on Rat Lung Alveolar Lining Liquid	1995 (Cycle IV)	$643,213
Lawrence Berkeley National Laboratory	Jacob Bastacky M.D.	4RT-0382

Effect of tobacco related policy change on smoking behavior	1999 (Cycle VIII)	$261,672
University of California, San Diego	David Burns M.D.	8RT-0094

Effect of tobacco smoke on leucocyte adhesion in vivo	2001 (Cycle X)	$1,023,946
La Jolla Institute for Molecular Medicine	Pragada Sriramarao Ph.D.	10RT-0171

Effect of tobacco smoke on leukocyte adhesion in vivo	1998 (Cycle VII)	$754,361
La Jolla Institute for Molecular Medicine	Pragada Sriramarao Ph.D.	7RT-0197

Effect of tobacco smoke on lung airway surface liquid	1998 (Cycle VII)	$115,658
Children's Hospital Oakland Research Institute	Jacob Bastacky M.D.	7RT-0133A

Effect of tobacco smoke on nitric oxide synthesis	1999 (Cycle VIII)	$70,000
University of California, Davis	Patrick Wong Ph.D.	8FT-0150

Effect of tobacco toxins on human germ cell development	2006 (Cycle XV)	$33,290
University of California, San Francisco	Kehkooi Kee Ph.D.	15FT-0178

Effect of tobacco toxins on human germ cell development	2006 (Cycle XV)	$41,710
Stanford University	Kehkooi Kee Ph.D.	15FT-0178A

Effect of tobacco-related policy change on smoking behavior	2002 (Cycle XI)	$303,504
University of California, San Diego	David Burns M.D.	11RT-0245

Effective diffusion of evidence-based tobacco curricula	2002 (Cycle XI)	$47,747
University of Southern California	Silvana Skara MPH	11DT-0137

Effectiveness Evaluation of the I Decide Program	2006 (Cycle XV)	$162,304
University of Southern California	Louise Rohrbach Ph.D., M.P.H.	15HT-1600

Effectiveness of a large prenatal tobacco reduction program	2004 (Cycle XIII)	$425,181
Sequoia Foundation	Michelle Pearl Ph.D.	13RT-0070

Effectiveness of two different regimens in smoking clinic	1999 (Cycle VIII)	$272,989
University of California, Los Angeles	Scott Eliot Sherman M.D., M.P.H.	8RT-0068

Effects of Disturbed Flow on Endothelial Cell Function	1995 (Cycle IV)	$52,345
University of California, Los Angeles	Henry Honda M.D.	4FT-0358

Effects of Environmental Tobacco Smoke on Pulmonary Allergy	1995 (Cycle IV)	$256,805
University of California, Davis	Laurel Gershwin D.V.M., Ph.D.	4RT-0299

Effects of environmental tobacco smoke on pulmonary allergy	1998 (Cycle VII)	$282,568
University of California, Davis	Laurel Gershwin D.V.M., Ph.D.	7RT-0107

Effects of environmental tobacco smoke on the artery wall	1998 (Cycle VII)	$449,673
University of California, Davis	John Rutledge M.D.	7RT-0070

Effects of exposure to secondhand smoke	1999 (Cycle VIII)	$194,404
Kaiser Foundation Research Institute	Carlos Iribarren M.D., Ph.D., M.P.H.	8KT-0028

Effects of Legislation on ETS Exposure in California	1997 (Cycle VI)	$245,189
University of California, San Diego	Arthur Farkas Ph.D.	6PT-5002

Effects of nicotine exposure in utero on brain cell death	1997 (Cycle VI)	$74,499
University of California, San Diego	Jerold Chun M.D., Ph.D.	6IT-0239

Effects of Nicotine on Brain Development	1999 (Cycle VIII)	$55,404
Cedars-Sinai Medical Center	Christine Cloak	8DT-0170

Effects of nicotine on fetal hematopoiesis	2007 (Cycle XVI)	$764,400
Torrey Pines Institute for Molecular Studies	Sophia Khaldoyanidi M.D., Ph.D.	16RT-0134

Effects of nicotine on hematopoietic stem cell migration	2005 (Cycle XIV)	$74,500
La Jolla Institute for Molecular Medicine	Naira Serobyan M.D.	14FT-0126

Effects of nicotine on postinfarction cardiac remodeling	1998 (Cycle VII)	$459,799
University of California, San Diego	Francisco Villarreal M.D., Ph.D.	7RT-0109H

Effects of nicotine on schizophrenia-like cognitive deficits	2006 (Cycle XV)	$60,000
University of California, San Diego	Nurith Amitai B.S.	15DT-0048

Effects of nicotine on taste processing	2001 (Cycle X)	$24,834
University of California, Davis	Christopher Simons Ph.D.	10DT-0197

Effects of nicotine withdrawal on aviator performance	2001 (Cycle X)	$515,243
Stanford University	Jerome Yesavage M.D.	10RT-0186

Effects of Outlet/Ad Density on Teen Smking and Brand Choice	2005 (Cycle XIV)	$410,979
Stanford University	Lisa Henriksen Ph.D.	14RT-0103

Effects of passive smoking and pregnancy	1999 (Cycle VIII)	$565,186
Lawrence Livermore National Laboratory	Kenneth Turteltaub Ph.D.	8RT-0072

Effects of perinatal nicotine on the Brain	1997 (Cycle VI)	$93,122
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Russell Poland Ph.D.	6IT-0071

Effects of prenatal nicotine exposure on nicotinic receptors	2000 (Cycle IX)	$471,654
University of California, San Francisco	Peter Sargent Ph.D.	9RT-0101

Effects of pro and anti-smoking cues in stores on craving	2004 (Cycle XIII)	$373,894
Stanford University	Lisa Henriksen Ph.D.	13RT-0123

Effects of PSA content and formal features on smoking norms	1999 (Cycle VIII)	$44,284
Stanford University	Michael Antecol Ph.D.	8FT-0149

Effects of Selegiline on craving for nicotine	1998 (Cycle VII)	$100,450
Stanford University	Joel Killen Ph.D.	7RT-0094

Effects of side stream tobacco smoke on DNA deletions	2005 (Cycle XIV)	$58,876
University of California, Los Angeles	Mitsuko Yamamoto B.S.	14DT-0121

Effects of social capital on smoking: elasticity & pathways	2005 (Cycle XIV)	$98,854
University of California, Berkeley	Richard Scheffler Ph.D.	14IT-0175

Effects of tobacco on inflammatory cell responses	1997 (Cycle VI)	$223,585
University of California, Davis	Lisa Miller Ph.D.	6KT-0411

Effects of tobacco smoke exposure on hormones and fertility	1998 (Cycle VII)	$115,335
Sequoia Foundation	Gayle Windham Ph.D.	7RT-0119

Effects of tobacco smoke on airway bactericidal activity	2001 (Cycle X)	$87,079
University of California, Davis	Yuan-Pu Di Ph.D.	10KT-0261

Effects of Tobacco Smoke on Mucin Production in Rat Airways	1995 (Cycle IV)	$356,400
University of California, San Francisco	Carol Basbaum Ph.D.	4RT-0210

Effects of Tobacco Taxation Upon Population Health Status	1997 (Cycle VI)	$206,547
University of California, San Diego	Robert Kaplan Ph.D.	6PT-2004

Effects of tobacco-induced gamete damage on embryogenesis	2004 (Cycle XIII)	$158,853
Lawrence Livermore National Laboratory	Francesco Marchetti Ph.D.	13RT-0140

Effects of tobacco-induced gamete damage on embryogenesis	2004 (Cycle XIII)	$608,740
Lawrence Berkeley National Laboratory	Francesco Marchetti Ph.D.	13RT-0140A

Efficacy of the nicotine patch in adolescents & young adults	2002 (Cycle XI)	$69,800
University of California, San Francisco	Mark Rubinstein M.D.	11FT-0233

Electrophysiological Effects of Perinatal Nicotine Exposure	1995 (Cycle IV)	$446,225
Scripps Research Institute	Cindy Ehlers Ph.D.	4RT-0285

Electrophysiological Effects of Perinatal Nicotine Exposure	1995 (Cycle IV)	$293,752
San Diego State University Research Foundation	Edward Riley Ph.D.	4RT-0285S

Emotional intelligence and smoking across ethnicity	2000 (Cycle IX)	$52,392
University of Southern California	Dennis Trinidad Ph.D., M.P.H.	9DT-0174

Engineering Salmonella for lung cancer therapy	2007 (Cycle XVI)	$291,600
Sidney Kimmel Cancer Center	Nabil Arrach Ph.D.	16KT-0045

Environmental contexts of smoking for Southeast Asians	2004 (Cycle XIII)	$728,324
Pacific Institute for Research and Evaluation	Juliet Lee BA, MA, PhD	13RT-0058H

Environmental influences on tobacco use amg AAPI communities	2004 (Cycle XIII)	$204,722
Asian Pacific Partners for Empowerment Advocacy & Leadership	Rod Lew MPH	13AT-3000A

Environmental influences on tobacco use amg AAPI communities	2004 (Cycle XIII)	$311,543
Assoc of Asian Pacific Community Health Organizations	Rod Lew MPH	13AT-3000

Environmental influences on tobacco use amg AAPI communities	2004 (Cycle XIII)	$149,610
CSU Fullerton Auxiliary Services Corporation	Sora Park Tanjasiri DrPH, MPH	13AT-3001

Environmental tobacco smoke and early atherosclerosis	1997 (Cycle VI)	$383,814
University of Southern California	Wendy Mack Ph.D.	6RT-0137

Environmental tobacco smoke and newborn lung development	1997 (Cycle VI)	$440,500
University of California, Davis	Kent Pinkerton Ph.D.	6RT-0327

Environmental tobacco smoke effects on lung surfactant	1999 (Cycle VIII)	$423,216
University of California, Santa Barbara	Joseph Zasadzinski Ph.D.	8RT-0077

Environmental tobacco smoke effects on lung surfactant	2002 (Cycle XI)	$406,444
University of California, Santa Barbara	Joseph Zasadzinski Ph.D.	11RT-0222

Environmental tobacco smoke effects on lung surfactant	1999 (Cycle VIII)	$47,656
University of California, Santa Barbara	Junqi Ding	8DT-0171

Environmental tobacco smoke exposure & adult asthma	2001 (Cycle X)	$460,032
University of California, San Francisco	Mark Eisner M.D., M.P.H.	10RT-0108

Enzymatic targets for anticancer therapy	2002 (Cycle XI)	$267,304
J. David Gladstone Institutes	Martin Bergo M.D., Ph.D.	11KT-0087

Epigenetic Regulation of Airway MUC gene expression by smoke	2007 (Cycle XVI)	$420,000
University of California, Davis	Reen Wu Ph.D.	16RT-0127

Ethnic and gender variation in nicotine detoxification	2003 (Cycle XII)	$424,142
SRI International	Huijun Ring Ph.D.	12KT-0234

Ethnic difference in cigarette smoking dynamics among youth	1999 (Cycle VIII)	$366,852
University of Southern California	Xinguang Chen Ph.D.	8RT-0034

Ethnicity and school-level effect on CA student tobacco use	2004 (Cycle XIII)	$422,120
University of California, Los Angeles	William McCarthy Ph.D.	13RT-0051H

ETS Effects on airway development in the primate lung	1998 (Cycle VII)	$483,652
University of California, Davis	Kent Pinkerton Ph.D.	7RT-0118

ETS effects on breathing patterns	2000 (Cycle IX)	$590,780
University of California, Davis	Jesse Joad M.D.	9RT-0010

ETS Effects on Lung Surfactant	2005 (Cycle XIV)	$419,000
University of California, Santa Barbara	Joseph Zasadzinski Ph.D.	14RT-0077

ETS effects on pulmonary breathing patterns	1997 (Cycle VI)	$446,954
University of California, Davis	Jesse Joad M.D.	6RT-0024

ETS exposures in the California Teachers Study cohort	1998 (Cycle VII)	$449,677
Public Health Institute	Peggy Reynolds Ph.D.	7RT-0142

Evaluating Mechanisms of Change in a Smoking Intervention	2008 (Cycle XVII)	$202,500
RAND Corporation	Harold Green Ph.D.	17IT-0007

Evaluation of ad strategies for preventing youth tobacco use	1997 (Cycle VI)	$136,953
University of California, Irvine	Cornelia Pechmann Ph.D.	6RT-0038

Evaluation of office ETS exposure in relation to AB 13	1999 (Cycle VIII)	$242,063
Public Health Institute	Leon Alevantis M.S.	8RT-0157

Evaluation of office ETS exposure in relation to AB13	1999 (Cycle VIII)	$208,554
Lawrence Berkeley National Laboratory	William Fisk B.S., M.S.	8RT-0157S

Experimental evaluation of minors' access to tobacco	2000 (Cycle IX)	$655,347
San Diego State University Research Foundation	Hope Landrine Ph.D.	9RT-0043

Explaining racial differences in smoking	1999 (Cycle VIII)	$151,430
San Diego State University Research Foundation	Hope Landrine Ph.D.	8RT-0013A

Explaining racial differences in smoking	1999 (Cycle VIII)	$149,280
Public Health Foundation Enterprises, Inc.	Hope Landrine Ph.D.	8RT-0013

Exploration of tobacco use in Asian Pacific Islander youth	2002 (Cycle XI)	$92,076
Assoc of Asian Pacific Community Health Organizations	Sora Park Tanjasiri DrPH, MPH	11BT-1600

Exploration of tobacco use in Asian Pacific Islander youth	2002 (Cycle XI)	$92,076
Assoc of Asian Pacific Community Health Organizations	Rod Lew MPH	11BT-1600

Exploring tobacco cessation services on CA college campuses	2001 (Cycle X)	$81,995
Public Health Institute	Dianne Barker M.H.S.	10IT-0265

Exploring transdisciplinary scientific collaboration	2001 (Cycle X)	$29,040
University of California, Irvine	Juliana Lynn Fuqua Ph.D.	10DT-0178

Expos children to secondhand smoke through cntaminated homes	2004 (Cycle XIII)	$754,504
San Diego State University Research Foundation	Georg Matt Ph.D.	13RT-0161H

Exposure to Secondhand Smoke: Effects of Proximity	2007 (Cycle XVI)	$672,582
Stanford University	Lynn Hildemann Ph.D.	16RT-0150

Expressing & Cloning of ATP-Sensitive Potassium Channels	1995 (Cycle IV)	$286,163
University of California, Santa Barbara	Carol Vandenberg Ph.D.	4RT-0289

Expression of the Human apo-B Gene in Transgenic Mice	1995 (Cycle IV)	$211,090
J. David Gladstone Institutes	Beatriz Levy-Wilson Ph.D.	4RT-0308

Expression of the Human apo-B Gene in Transgenic Mice	1995 (Cycle IV)	$569,759
Palo Alto Medical Foundation Research Institute	Beatriz Levy-Wilson Ph.D.	4RT-0308A

Family factors in smoking acquisition among Latino youth	1998 (Cycle VII)	$865,636
San Diego State University Research Foundation	Rafael Laniado-Laborin M.D., MPH	7RT-0049

Fertility smoking and early mammalian development	2004 (Cycle XIII)	$392,451
University of California, Riverside	Prudence Talbot Ph.D.	13RT-0068

Fertility, smoking and early mammalian development	1997 (Cycle VI)	$452,243
University of California, Riverside	Prudence Talbot Ph.D.	6RT-0039

Fertility, smoking and early mammalian development	2001 (Cycle X)	$454,490
University of California, Riverside	Prudence Talbot Ph.D.	10RT-0239

Fertility, Smoking, and Early Mammalian Development	1995 (Cycle IV)	$321,193
University of California, Riverside	Prudence Talbot Ph.D.	4RT-0081

Focal adhesion kinase regulation of Cox-2 in lung cancer	2003 (Cycle XII)	$74,520
Scripps Research Institute	Satyajit Mitra Ph.D.	12FT-0122

Function and Regulation of the Retinoblastoma Protein	1995 (Cycle IV)	$385,031
University of California, San Diego	James Feramisco Ph.D.	4RT-0251

Functional Antagonists of Nicotine	1995 (Cycle IV)	$236,936
Northern California Institute for Research & Education	S. Paul Berger M.D.	4KT-0313

Functional MRI of neural activation	1997 (Cycle VI)	$48,447
University of California, Los Angeles	Shantanu Sinha Ph.D.	6IT-0255

Functional significance of the protein CD40 in lung cancer	1998 (Cycle VII)	$35,000
University of California, San Diego	Kenneth Grudko M.D.	7FT-0047

Functions of IRF-1 and Smad3 interaction in lung cancer	2001 (Cycle X)	$69,750
University of California, San Francisco	Pierre Lee Ph.D.	10FT-0141

Fusion proteins that convert VEGF into a cell death factor	2007 (Cycle XVI)	$100,000
University of California, San Francisco	Timothy Quinn M.D.	16IT-0009

Gastroschisis: maternal smoking and genetic variation	2007 (Cycle XVI)	$673,269
Children's Hospital Oakland Research Institute	Edward Lammer M.D.	16RT-0086

Gene Augmentation Therapy for Tobacco Induced Emphysema	1995 (Cycle IV)	$224,786
University of California, Davis	Robert Malone M.D.	4KT-0205

Gene Markers for Hypertension	1995 (Cycle IV)	$356,151
University of California, San Francisco	Theodore Kurtz M.D.	4RT-0362

Gene therapy for emphysema	1997 (Cycle VI)	$443,179
University of California, San Francisco	Francis Szoka Ph.D.	6RT-0109

Genes affecting nicotine response in C. elegans	2006 (Cycle XV)	$100,000
University of California, San Diego	William Schafer Ph.D.	15RT-0216

Genetic links to nicotine addiction: ethics of testing teens	1999 (Cycle VIII)	$115,591
Stanford University	Thomas Raffin M.D.	8IT-0123

Genetic Susceptibility to Lung Cancer	1995 (Cycle IV)	$104,580
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Henry Lin M.D.	4IT-0130

Genetic susceptibility to tobacco-induced lung cancer	1998 (Cycle VII)	$406,120
University of California, Los Angeles	Oliver Hankinson Ph.D.	7RT-0061

Genetics and Impulsivity in Smoking Initiation	2008 (Cycle XVII)	$283,612
Veterans Medical Research Foundation	Neal Doran Ph.D.	17KT-0027

Genomic Assay to Identify Targets of Anticancer Therapeutics	2008 (Cycle XVII)	$75,000
Stanford University	Nolan Ko Ph.D.	17FT-0056

Genomics & transcriptome of oral precncr prgrssion in smkers	2004 (Cycle XIII)	$189,541
University of California, Los Angeles	Xiaofeng Zhou Ph.D.	13KT-0028

Geography of underage tobacco retail sales in Los Angeles	2003 (Cycle XII)	$622,260
Pacific Institute for Research and Evaluation	Robert Lipton BA, MA, MPH, Ph.D.	12RT-0093

Global determinants of tobacco use onset in diverse youth	1998 (Cycle VII)	$280,749
Education Training and Research Associates, Inc.	Scott Carvajal Ph.D., MPH	7KT-0151H

Grainyhead-Like Transcription factor in Airway Epithelium	2008 (Cycle XVII)	$60,000
University of California, Irvine	Ambica Bhandari Masters in Biotechnology	17DT-0192

Heat shock proteins as biomarkers of lung oxidant stress	2000 (Cycle IX)	$24,338
University of California, Davis	Kurt Williams D.V.M.	9DT-0204

Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke	1995 (Cycle IV)	$454,365
Lawrence Berkeley National Laboratory	Rolf Mehlhorn Ph.D.	4RT-0240

Heparan sulfate small molecules for contro tumor cell growth	2005 (Cycle XIV)	$626,807
California Institute of Technology	Linda Hsieh-Wilson Ph.D.	14RT-0034

-Heterologous Expression of Brain Nicotinic Acetylcholine Re	1995 (Cycle IV)	$598,774
California Institute of Technology	Henry Lester Ph.D.	4RT-0286

High Resolution OCT for Early Airway Cancer Detection	2007 (Cycle XVI)	$480,636
University of California, Irvine	Matthew Brenner M.D.	16RT-0082

Hmong cultural practices and patterns of tobacco use	1999 (Cycle VIII)	$83,383
California Health Collaborative	Vickie Krenz Ph.D., M.S.P.H.	8IT-0079

Hmong smoking prevalence & tobacco uses	2001 (Cycle X)	$539,350
California State University, Fresno Foundation	Vickie Krenz Ph.D., M.S.P.H.	10AT-1101

Hmong smoking prevalence & tobacco uses	2001 (Cycle X)	$539,350
California State University, Fresno Foundation	Pao Fang	10AT-1101

Hormone replacement therapy, smoking & lipoprotein oxidation	1998 (Cycle VII)	$385,808
Scripps Research Institute	Carole Banka Ph.D.	7RT-0101

Hormone replacement therapy, smoking & lipoprotein oxidation	1998 (Cycle VII)	$245,584
La Jolla Institute for Molecular Medicine	Carole Banka Ph.D.	7RT-0101A

Hormones and Tobacco: Joint Effects on Reproduction	1994 (Cycle III)	$263,611
Public Health Institute	Shanna Swan Ph.D.	3RT-0093

How are beneficial cholesterol transport proteins produced?	1998 (Cycle VII)	$37,069
J. David Gladstone Institutes	Martin Hersberger Ph.D.	7FT-0005

How do nic and cig smoke affect neural control of breathing?	2004 (Cycle XIII)	$392,620
University of California, Los Angeles	Xuesi Shao M.D.	13RT-0164

How do tobacco smoke compounds impair lung surfactant?	1997 (Cycle VI)	$74,961
University of California, Santa Barbara	Joseph Zasadzinski Ph.D.	6IT-0140

How does cardiac fuel metabolism influence heart disease?	1998 (Cycle VII)	$262,005
J. David Gladstone Institutes	Murielle Marie Veniant Ph.D.	7KT-0020

How does cigarette smoke induce cancer?	1997 (Cycle VI)	$811,518
Beckman Research Institute of the City of Hope	Gerd Pfeifer Ph.D.	6RT-0361

How does smoke activate mucin transcription in lung cells?	1998 (Cycle VII)	$432,415
University of California, San Francisco	Carol Basbaum Ph.D.	7RT-0152

How omega-3 fatty acids prevent or slow cancer	2006 (Cycle XV)	$74,808
The Burnham Institute for Medical Research	Hu Zhou Ph.D.	15FT-0243

How smoke induces lung damage via oxidative stress	2006 (Cycle XV)	$75,000
University of California, Davis	Michal Levy Ph.D.	15FT-0041

Human neurophysiology of nicotine analgesia: sex differences	2000 (Cycle IX)	$595,994
University of California, San Francisco	David Becker Ph.D.	9RT-0142

Human oocyte development and PAH exposure	2005 (Cycle XIV)	$260,944
University of California, San Francisco	Renee Reijo Pera Ph.D.	14RT-0159

Human oocyte development and PAH exposure	2005 (Cycle XIV)	$158,556
Stanford University	Renee Reijo Pera Ph.D.	14RT-0159A

Human tryptase gene expression: role in COPD	2000 (Cycle IX)	$545,409
University of California, San Francisco	George Caughey M.D.	9RT-0152H

Hyperactive nicotine receptors	1997 (Cycle VI)	$486,158
California Institute of Technology	Henry Lester Ph.D.	6RT-0044

Hyperactive nicotine receptors	2000 (Cycle IX)	$1,138,225
California Institute of Technology	Henry Lester Ph.D.	9RT-0182

Hyperactive nicotine receptors	2003 (Cycle XII)	$675,487
California Institute of Technology	Henry Lester Ph.D.	12RT-0245

Hypnosis for Smoking Relapse Prevention	2007 (Cycle XVI)	$509,353
University of California, San Francisco	Timothy Carmody Ph.D.	16RT-0074

IAP Antagonists for lung cancer treatment	2004 (Cycle XIII)	$727,658
The Burnham Institute for Medical Research	John Reed M.D., Ph.D.	13RT-0130

Identification on Tumors of Molecular Targets for NK Cells	1995 (Cycle IV)	$314,006
University of California, San Francisco	William Seaman M.D.	4RT-0184

IL-12 genetic immunotherapy for lung cancer	1999 (Cycle VIII)	$75,000
University of California, Los Angeles	Steven Dubinett M.D.	8IT-0035

Immune Targeted Therapy for Lung Cancer	2006 (Cycle XV)	$419,500
University of California, Los Angeles	Sherven Sharma Ph.D.	15RT-0207

Immunopharmacotherapy as a treatment for nicotine addiction	2002 (Cycle XI)	$515,270
Scripps Research Institute	Kim Janda Ph.D.	11RT-0174

Impact of Cultural Competence on Treatment Outcomes	2002 (Cycle XI)	$1,500
University of California, Davis	Nolan Zane Ph.D.	11ST-0259

Impact of MPO in Tobacco-related Cardiovascular Disease	2007 (Cycle XVI)	$818,160
Sidney Kimmel Cancer Center	Wanda Reynolds Ph.D.	16RT-0184

Impact of nicotinic signaling on neuronal gene expression	2000 (Cycle IX)	$30,055
University of California, San Diego	Karen Chang B.A.	9DT-0147

Impact of Positive Mood on Self-Control Depletion in Smoking	2007 (Cycle XVI)	$75,000
University of California, San Francisco	Dikla Shmueli Ph.D.	16FT-0050

Implementation of California AB 13: smoking ban in bars	1998 (Cycle VII)	$315,181
University of California, San Francisco	Lisa Bero Ph.D.	7RT-0180

Implementation of tobacco prevention programming and smoking	2003 (Cycle XII)	$58,557
University of Southern California	Pamela Elfenbaum MPH	12DT-0152

Implementation of tobacco programs in Calif schools	2000 (Cycle IX)	$765,192
University of Southern California	Louise Rohrbach Ph.D., M.P.H.	9RT-0107

Importance of Rce1 and Ras in tobacco-induced cancers	1999 (Cycle VIII)	$75,209
J. David Gladstone Institutes	Martin Bergo M.D., Ph.D.	8FT-0137

Improved chemoradiotherapy of lung cancer	2005 (Cycle XIV)	$661,920
California Pacific Medical Center Research Institute	Li-Xi Yang M.D., Ph.D.	14RT-0177

Improved therapy of lung cancer	2000 (Cycle IX)	$668,814
California Pacific Medical Center Research Institute	Li-Xi Yang M.D., Ph.D.	9RT-0172

Improving tobacco use assessment among youth via telephone	1997 (Cycle VI)	$347,440
University of California, Berkeley	Joel Moskowitz Ph.D.	6RT-0371

Individual and gender differences in nicotine sensitivity	2003 (Cycle XII)	$69,495
University of California, Irvine	Minjung Park Ph.D.	12FT-0247

Indoor measurements of environmental tobacco smoke	1997 (Cycle VI)	$634,217
Lawrence Berkeley National Laboratory	Richard Sextro Ph.D.	6RT-0307

Inflammation, innate immunity, TLRs, and atherosclerosis	2002 (Cycle XI)	$697,650
Scripps Research Institute	Peter Tobias Ph.D.	11RT-0073

Inflammatory compounds:role in tobacco-related lung disease	1998 (Cycle VII)	$447,367
University of California, San Diego	Timothy Bigby M.D.	7RT-0097

Influences that promote ethnic disparities in smoking	2003 (Cycle XII)	$269,971
University of California, San Diego	Dennis Trinidad Ph.D., M.P.H.	12KT-0158

Inheritance and Smoking in Urinary Tract & Pancreas Cancer	1995 (Cycle IV)	$248,283
University of Southern California	Thomas Mack M.D., M.P.H.	4RT-0324

Inhibition of cell death in head and neck cancer cells	2005 (Cycle XIV)	$24,148
University of Southern California	Ram Kumar Subramanyan M.D.	14DT-0125

Inhibition of MYC-activated gene expression by polyamides	2007 (Cycle XVI)	$75,000
California Institute of Technology	Daniel Harki Ph.D.	16FT-0055

Innovation to prevent post-partum relapse	2000 (Cycle IX)	$75,000
University of California, San Francisco	Jennifer Haas M.D.	9IT-0192

Instant SHS Feedback as a Catalyst for Smoke-Free Homes	2008 (Cycle XVII)	$129,917
San Diego State University Research Foundation	Neil Klepeis	17IT-0008

Integrin Cytoplasmic Domains and Ligand Affinity Modulation	1994 (Cycle III)	$522,649
Scripps Research Institute	Timothy O'Toole Ph.D.	3RT-0320

Integrin receptors and heart disease	2005 (Cycle XIV)	$35,323
University of California, San Diego	Anthony Partridge Ph.D.	14FT-0033

Integrins and drug resistance in small cell lung cancer	2003 (Cycle XII)	$780,144
The Burnham Institute for Medical Research	Kristiina Vuori M.D., Ph.D.	12RT-0143

Interaction of LDL receptor family members with ligands	2008 (Cycle XVII)	$291,600
Children's Hospital Oakland Research Institute	Taichi Yamamoto Ph.D.	17KT-0026

Interactions of Moesin during platelet activation	1995 (Cycle IV)	$428,524
Stanford University	Heinz Furthmayr M.D.	4RT-0316

Interdependence - smoking behavior & mood in natural setting	1997 (Cycle VI)	$222,843
University of California, Los Angeles	Richard Olmstead Ph.D.	6KT-0322

Internet health research center: smoking, Latinos, & the Web	2004 (Cycle XIII)	$535,096
University of California, San Francisco	Ricardo Munoz Ph.D.	13RT-0050H

Internet-enhanced proactive telephone counseling	2002 (Cycle XI)	$674,731
Veterans Medical Research Foundation	Leslie Lenert M.D., M.S.	11RT-0096

Investigating College Student Cigarette Smoking Self-change	2007 (Cycle XVI)	$138,596
Veterans Medical Research Foundation	Mark Myers Ph.D.	16IT-0208

Involvement of PI3K pathway in bladder cancer invasion	2002 (Cycle XI)	$224,984
University of California, Davis	Colleen Sweeney Ph.D.	11KT-0236

IRAK-1 & active TGF-beta: Counter-regulators in emphysema?	2003 (Cycle XII)	$69,000
University of California, San Francisco	George Su M.D.	12FT-0123

Irritant & Analgesic Effects of Nicotine	1995 (Cycle IV)	$75,000
University of California, Davis	Earl Carstens Ph.D.	4IT-0087

Irritant and analgesic effects of nicotine	2002 (Cycle XI)	$226,650
University of California, Davis	Earl Carstens Ph.D.	11RT-0053

Irritant and pain-reducing effects of nicotine	1997 (Cycle VI)	$415,704
University of California, Davis	Earl Carstens Ph.D.	6RT-0231

Isolation of a Tumor Promoter Induced C-Fos Kinase	1995 (Cycle IV)	$55,000
University of California, San Diego	Tuula Kallunki Ph.D.	4FT-0105

Isolation of lung tumor proteins for a novel treatment	1998 (Cycle VII)	$75,000
University of California, San Diego	Michael Kelner M.D., M.S.	7IT-0001

Isothiocyantes among African Americans and Caucasions	2002 (Cycle XI)	$73,270
University of California, Irvine	Catherine Carpenter M.P.H., Ph.D.	11IT-0082

Keep me smokefree	1998 (Cycle VII)	$550,002
Education Training and Research Associates, Inc.	Carol D'Onofrio DrPH	7RT-0090

Latino and Asian American college students' smoking	2003 (Cycle XII)	$59,500
University of California, Riverside	Michiko Otsuki Ph.D.	12DT-0157

LDL pathophysiology and lipoprotein structure	2003 (Cycle XII)	$527,245
Children's Hospital Oakland Research Institute	Robert Ryan Ph.D.	12RT-0014

Lesbian, gay, bisexual and transgender tobacco use	2004 (Cycle XIII)	$302,119
Kaiser Foundation Research Institute	Elisabeth Gruskin DrPH	13RT-0084

Life histories: Chinese-American elders' smoking encounters	2000 (Cycle IX)	$17,146
Stanford University	Matthew Kohrman Ph.D.	9IT-0066

Lifetime passive smoke exposure and breast cancer in the CTS	2004 (Cycle XIII)	$285,300
Northern California Cancer Center	Peggy Reynolds Ph.D.	13RT-0018A

Lifetime passive smoke exposure and breast cancer in the CTS	2004 (Cycle XIII)	$122,659
Public Health Institute	Peggy Reynolds Ph.D.	13RT-0018

Lipoprotein classes and susceptibility to atherosclerosis	1998 (Cycle VII)	$702,940
J. David Gladstone Institutes	Stephen Young M.D.	7RT-0032

Liposome targeted chemotherapy to treat lung cancer	1999 (Cycle VIII)	$75,000
University of California, San Francisco	Francis Szoka Ph.D.	8IT-0138

Long-term adherence after pulmonary rehabilitation for COPD	2001 (Cycle X)	$56,118
University of California, San Diego	Pia Santiago B.A.	10DT-0212

Low-Cost Contingency Management for Smoking Cessation	2008 (Cycle XVII)	$478,751
University of California, San Francisco	Timothy Carmody Ph.D.	17RT-0081

Lowering Smoking & ETS Risks in Immigrant Pacific Rim Youth	1998 (Cycle VII)	$1,955,276
University of Southern California	C. Anderson Johnson Ph.D.	7PT-7002

Lung cancer therapy with in vivo-generated dendritic cells	2001 (Cycle X)	$225,000
University of California, Los Angeles	Saroj Basak	10KT-0086

Lung cancer treatment: The total synthesis of ineleganolide	2005 (Cycle XIV)	$59,700
California Institute of Technology	Jennifer Roizen B.A.	14DT-0004

Lung volume reduction surgery in an animal emphysema model	2000 (Cycle IX)	$456,336
University of California, Irvine	Matthew Brenner M.D.	9RT-0094

Lung volume reduction surgery in an emphysema model	1997 (Cycle VI)	$404,139
University of California, Irvine	Matthew Brenner M.D.	6RT-0158

Macrophage DAP12 pathway in emphysema	2007 (Cycle XVI)	$387,237
University of California, San Francisco	Laura Koth M.D.	16RT-0072

Macrophage function in atherosclerosis	2000 (Cycle IX)	$709,200
Scripps Research Institute	Linda Curtiss Ph.D.	9RT-0161

Macular pigment regeneration upon smoking cessation	1997 (Cycle VI)	$74,988
University of California, Berkeley	Theodore Cohn Ph.D.	6IT-0324

Major Local Tobacco Control Ordinances in the United States	1997 (Cycle VI)	$26,244
American Nonsmokers' Rights Foundation	Robin Hobart M.P.P., M.P.H.	6ST-0454

Mapping of Genetic Loci for Nicotine Dependence	1998 (Cycle VII)	$982,095
Ernest Gallo Clinic and Research Center	Kirk Wilhelmsen M.D., Ph.D.	7PT-2003

Marketing low-tar cigarettes and new harm-reduced products	2005 (Cycle XIV)	$74,500
University of California, San Francisco	Stacey Anderson Ph.D.	14FT-0013

Maternal DNA repair of tobacco-induced sperm lesions	1998 (Cycle VII)	$1,046,880
Lawrence Livermore National Laboratory	Andrew Wyrobek Ph.D.	7RT-0073

Maternal Smoking Habit Modification Via Fetal Visualization	1995 (Cycle IV)	$54,471
University of California, San Diego	Dolores Pretorius M.D.	4IT-0218A

MCP-1 and TGFb in pulmonary emphysema	2002 (Cycle XI)	$78,241
University of California, San Francisco	David Morris M.D.	11KT-0223

Measuring adolescent smoking cessation motives and methods	2001 (Cycle X)	$103,273
Veterans Medical Research Foundation	Mark Myers Ph.D.	10IT-0280

Measuring prenatal tobacco exposure in newborn blood spots	2008 (Cycle XVII)	$506,927
Sequoia Foundation	Juan Yang Ph.D.	17RT-0138

Mechanism of apparent long-term nicotinic inactivation	2000 (Cycle IX)	$20,565
University of California, Riverside	Li Jia M.S.	9DT-0156

Mechanism of DNA break repair in germline cells	2007 (Cycle XVI)	$75,000
University of California, Davis	Amitabh Nimonkar Ph.D.	16FT-0069

Mechanism of nicotine action in developing lung	2000 (Cycle IX)	$720,281
University of Southern California	Carol Wuenschell Ph.D.	9RT-0238

Mechanism of smoke-induced MUC5B gene expression	2001 (Cycle X)	$392,117
University of California, Davis	Reen Wu Ph.D.	10RT-0262

Mechanism of stress effects on weight in nicotine withdrawal	1998 (Cycle VII)	$407,019
University of California, San Francisco	Jon Levine M.D., Ph.D.	7RT-0068

Mechanism of TGF-a shedding in lung cancer development	2003 (Cycle XII)	$69,600
University of California, San Francisco	Yang Xiao Ph.D.	12FT-0179

Mechanisms by which tobacco accelerates atherosclerosis	1998 (Cycle VII)	$675,731
Stanford University	John Cooke M.D., Ph.D.	7RT-0128

Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco	1994 (Cycle III)	$314,974
Stanford University	Gary Gibbons M.D.	3KT-0375

Mechanisms of targeted therapy resistance in lung cancer	2006 (Cycle XV)	$358,500
University of California, Los Angeles	Kostyantyn Krysan Ph.D.	15RT-0152

Mechanisms of Tobacco-Induced Retinal Neovascularization	2006 (Cycle XV)	$155,550
Stanford University	John Cooke M.D., Ph.D.	15IT-0257

Mechanisms of Tumor Suppressor in Lung Cancer Initiation	2008 (Cycle XVII)	$75,000
University of California, Davis	Jie Liu Ph.D.	17FT-0046

Mechanisms underlying diaphragm adaptations in emphysema	1998 (Cycle VII)	$642,624
Cedars-Sinai Medical Center	Mario Fournier Ph.D.	7RT-0161

Mechanisms underlying modulations of respiration by nicotine	2001 (Cycle X)	$330,458
University of California, Los Angeles	Xuesi Shao M.D.	10RT-0241

Media and smoking among adolescent girls across ethnicity	1999 (Cycle VIII)	$53,987
University of Southern California	Dongyun Yang M.D.	8DT-0175

Membrane proteins and TGF-alpha/EGFR: a role in lung cancer?	1999 (Cycle VIII)	$40,436
University of California, San Francisco	Wen Shi Ph.D.	8FT-0033

Membrane Signaling Pathways of RAS/RAB Proteins	1995 (Cycle IV)	$574,559
Scripps Research Institute	William Balch Ph.D.	4RT-0222

Mentholated cigarettes and risk of acute MI, CHD, and stroke	2002 (Cycle XI)	$106,246
Kaiser Foundation Research Institute	Stephen Sidney M.D.	11IT-0203

Methyl-DNA Binding Protein Regulation and Function	1999 (Cycle VIII)	$54,546
University of California, San Diego	Darren Casteel	8DT-0169

Micro RNA and dopamine-induced dentritic protein synthesis	2005 (Cycle XIV)	$59,000
California Institute of Technology	Hwan-Ching Tai B.S.	14DT-0040

Mild carbon monoxide exposure impairs the inner ear	2005 (Cycle XIV)	$397,320
University of California, Los Angeles	Ivan Lopez Ph.D.	14RT-0043H

Mitotic spindle checkpoint & chromosomal instability	2000 (Cycle IX)	$69,500
Ludwig Institute for Cancer Research	Zahid Bonday Ph.D.	9FT-0207

Mobilized dendritic cells for lung cancer	2000 (Cycle IX)	$950,821
Stanford University	Edgar Engleman M.D.	9RT-0229

Model for surveillance of CA tobacco control policies	2001 (Cycle X)	$325,761
Pacific Institute for Research and Evaluation	Harold Holder Ph.D.	10RT-0102

Modeling cost/effectiveness of tobacco control programs	2002 (Cycle XI)	$129,915
University of California, San Diego	Robert Kaplan Ph.D.	11RT-0243

Modeling cost/effectiveness of tobacco control programs	2002 (Cycle XI)	$23,238
University of California, Los Angeles	Robert Kaplan Ph.D.	11RT-0243A

Modeling ETS Exposure and Dose Using PDA E-Diaries	2006 (Cycle XV)	$291,531
San Diego State University Research Foundation	Marilyn Johnson-Kozlow Ph.D.	15KT-0175

Modeling sleep disturbance during nicotine withdrawal	2002 (Cycle XI)	$424,344
SRI International	Teresa Steininger Ph.D.	11KT-0218

Modeling the relation of smoking to the ovarian function	1999 (Cycle VIII)	$53,448
University of California, Davis	Yan Liu M.D.	8DT-0172

Modulating TLR9 Activation for Lung Cancer Therapy	2007 (Cycle XVI)	$762,411
Scripps Research Institute	Tsung-Hsien Chuang Ph.D.	16RT-0103

Molecular Dynamics & Regulation of Apo A-I's Conformation	2007 (Cycle XVI)	$644,293
Children's Hospital Oakland Research Institute	Michael Oda Ph.D.	16RT-0163

Molecular neurobiology of nicotine addiction	2001 (Cycle X)	$263,298
University of California, Los Angeles	Jim Boulter Ph.D.	10RT-0136

Molecular origins of ApoB atherogenic lipoproteins	2000 (Cycle IX)	$445,617
University of California, San Francisco	Robert Hamilton Ph.D.	9RT-0227

Molecular predictors of oral cancer development	2002 (Cycle XI)	$419,000
University of California, San Francisco	Richard Charles Jordan D.D.S., Ph.D.	11RT-0141

Molecular targets for tobacco oxidants in lung cell death	2001 (Cycle X)	$70,000
University of California, Davis	Tommer Ravid Ph.D.	10FT-0134

Monitoring exposure to tobacco-specific nitrosamines	1999 (Cycle VIII)	$74,999
University of California, Riverside	Thomas Morton Ph.D.	8IT-0058

Motivational interviewing to prevent postpartum relapse	1997 (Cycle VI)	$282,502
Kaiser Foundation Research Institute	Virginia Quinn MPH	6KT-0206

Motivation-enhanced teenage tobacco use cessation	1997 (Cycle VI)	$750,248
University of Southern California	Steve Sussman Ph.D.	6RT-0182

Multibehavioral changes for disease prevention among smokers	2002 (Cycle XI)	$69,824
University of California, San Francisco	Judith Prochaska Ph.D., M.P.H.	11FT-0013

Natural history of tobacco addiction in adolescents	1998 (Cycle VII)	$499,505
University of California, San Francisco	Anna-Barbara Moscicki M.D.	7RT-0195

Negative effects of smoke on novel HDL mimetic therapies	2008 (Cycle XVII)	$661,125
Lawrence Berkeley National Laboratory	John Bielicki Ph.D.	17RT-0082

Neural mechanisms underlying nicotine as a 'gateway' drug	2007 (Cycle XVI)	$60,000
University of California, Irvine	Susan McQuown B.A.	16DT-0189

Neuroadaptations underlying nicotine dependence	2002 (Cycle XI)	$60,379
Scripps Research Institute	Adrie Bruijnzeel Ph.D.	11FT-0112

Neurobehavioral consequences of adolescent nicotine exposure	2000 (Cycle IX)	$120,000
Scripps Research Institute	Cindy Ehlers Ph.D.	9RT-0210

Neurobehavioral consequences of adolescent nicotine exposure	2001 (Cycle X)	$630,710
Scripps Research Institute	Cindy Ehlers Ph.D.	10RT-0334

Neurobiological substrates of nicotine addiction	2003 (Cycle XII)	$723,613
Scripps Research Institute	Athina Markou Ph.D.	12RT-0231

Neurobiological substrates of nicotine addiction	2006 (Cycle XV)	$419,503
University of California, San Diego	Athina Markou Ph.D.	15RT-0022

Neurobiological substrates of nicotine addiction	1998 (Cycle VII)	$742,393
Scripps Research Institute	Athina Markou Ph.D.	7RT-0004

Neurobiological substrates of nicotine addiction	2001 (Cycle X)	$402,852
Scripps Research Institute	Athina Markou Ph.D.	10RT-0074

Neuroendocrine responses to nicotine: a physiologic probe	1998 (Cycle VII)	$225,000
University of California, San Francisco	Lori Karan M.D.	7KT-0031

Neuronal nicotinic receptor trafficking in nicotine addictio	2001 (Cycle X)	$71,664
California Institute of Technology	Raad Nashmi Ph.D.	10FT-0174

Neuronal oxidative stress from mild carbon monoxide exposure	2005 (Cycle XIV)	$418,972
University of California, Los Angeles	John Edmond Ph.D.	14RT-0068

Neuropharmacology of nicotine relapse	2003 (Cycle XII)	$149,175
Cedars-Sinai Medical Center	Xiu Liu M.D., Ph.D.	12KT-0188

Neurotoxic effects of nicotine: anatomy, mechanisms, effects	1999 (Cycle VIII)	$183,424
University of California, Los Angeles	Gaylord Ellison Ph.D.	8RT-0005

Neurotransmitter systems and tobacco smoking	1999 (Cycle VIII)	$430,910
University of California, Los Angeles	Richard Olmstead Ph.D.	8RT-0078H

New methods for searching tobacco industry documents	2003 (Cycle XII)	$59,551
University of California, San Francisco	Martha Michel M.S.	12DT-0186

New therapy for lung cancer using radioiodide	2000 (Cycle IX)	$225,000
University of California, Los Angeles	Min Huang M.D., M.S.	9KT-0215

Next Generation Califronai Tobacco Control Alliance	2003 (Cycle XII)	$3,890
Next Generation Alliance	Traci Verardo	12ST-0266

NF-kB mediated inflammation in tobacco-induced lung cancer	2006 (Cycle XV)	$420,000
University of California, San Diego	Michael Karin Ph.D.	15RT-0197

Nicotine & behavioral regulation in adult ADHD	2005 (Cycle XIV)	$495,092
University of California, Irvine	Jean-G. Gehricke Ph.D.	14RT-0147H

Nicotine & cardiac vulnerability to fibrillation	2000 (Cycle IX)	$120,000
Cedars-Sinai Medical Center	Hrayr Karagueuzian Ph.D.	9RT-0041

Nicotine & its metabolites: apoptosis in developing neurons	2000 (Cycle IX)	$412,200
Human BioMolecular Research Institute	Jun Zhang Ph.D.	9KT-0228

Nicotine & Neuroendocrine Cell Signalling in Fetal Lung	1995 (Cycle IV)	$349,873
University of Southern California	Carol Wuenschell Ph.D.	4KT-0339

Nicotine and cardiac vulnerability to fibrillation	2002 (Cycle XI)	$641,821
Cedars-Sinai Medical Center	Hrayr Karagueuzian Ph.D.	11RT-0058

Nicotine and cardiac vulnerability to fibrillation	1997 (Cycle VI)	$370,057
Cedars-Sinai Medical Center	Hrayr Karagueuzian Ph.D.	6RT-0020

Nicotine and congenital heart disease	2008 (Cycle XVII)	$629,797
Stanford University	Ching-Pin Chang M.D., PH.D	17RT-0102

Nicotine and Smoking Effects on Neuromuscular Development	1995 (Cycle IV)	$412,639
Cedars-Sinai Medical Center	Mario Fournier Ph.D.	4RT-0132

Nicotine dependence & schizophrenia	2001 (Cycle X)	$75,600
Scripps Research Institute	Svetlana Semenova Ph.D.	10FT-0323

Nicotine Disrupts PTHrP-Driven Paracrine Signaling Globally	2006 (Cycle XV)	$133,126
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Virender Rehan M.D.	15IT-0250

Nicotine effects on gene expression and metaplasticity	2004 (Cycle XIII)	$74,500
Stanford University	Damian Wheeler B.SC., Ph.D.	13FT-0059

Nicotine effects on neurological development	1999 (Cycle VIII)	$189,233
University of California, Irvine	Raju Metherate Ph.D.	8RT-0059

Nicotine effects on renal function in experimental diabetes	2000 (Cycle IX)	$98,313
University of California, San Diego	Francis Gabbai M.D.	9RT-0169

Nicotine in the Brain	2000 (Cycle IX)	$518,966
University of California, San Diego	Darwin Berg Ph.D.	9RT-0221

Nicotine May Affect Inflammation	1999 (Cycle VIII)	$435,425
University of California, San Francisco	Frederick Jia-Pei Miao M.D., Ph.D.	8RT-0032

Nicotine Metabolism in Families	1998 (Cycle VII)	$465,537
University of California, San Francisco	Neal Benowitz M.D.	7PT-2004

Nicotine modifies cardiac growth during adolescence	2007 (Cycle XVI)	$138,600
Veterans Medical Research Foundation	Wilbur Lew M.D.	16IT-0007

Nicotine pharmacogenetics: influence of ethnicity	1997 (Cycle VI)	$242,344
Cedars-Sinai Medical Center	Russell Poland Ph.D.	6RT-0069A

Nicotine pharmacogenetics: influence of ethnicity	1997 (Cycle VI)	$366,244
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Russell Poland Ph.D.	6RT-0069

Nicotine Receptors: Role in Nicotine Addiction	2006 (Cycle XV)	$20,748
California Institute of Technology	Ryan Drenan Ph.D.	15FT-0030

Nicotine recp mediated dopamine release and chronic nicotine	2006 (Cycle XV)	$75,000
The Parkinson's Institute	Xiomara Perez Ph.D.	15FT-0073

Nicotine regulates cardiac toxicity with lipopolysaccharide	2000 (Cycle IX)	$100,000
University of California, San Diego	Wilbur Lew M.D.	9RT-0166

Nicotine regulation of the noradrenergic system	2000 (Cycle IX)	$52,375
University of California, Irvine	Kathryn O'Leary M.S., Ph.D.	9DT-0115

Nicotine replacement in school-based cessation	2000 (Cycle IX)	$961,266
University of Southern California	Clyde Dent Ph.D.	9HT-3201

Nicotine replacement in school-based cessation	2000 (Cycle IX)	$961,266
University of Southern California	Rita Leeseman	9HT-3201

Nicotine replacement therapy: pharmacists' counseling role	1998 (Cycle VII)	$113,929
SRI International	Karen Hudmon Dr.P.H., R.P.H., M.S.	7IT-0169

Nicotine self-administration in an animal model	2003 (Cycle XII)	$660,156
Scripps Research Institute	George Koob Ph.D.	12RT-0099

Nicotine Self-Administration in an Animal Model	2008 (Cycle XVII)	$720,434
Scripps Research Institute	George Koob Ph.D.	17RT-0095

Nicotine synapse formation in the hippocampus	2005 (Cycle XIV)	$59,500
University of California, San Diego	Kerri Massey B.A.	14DT-0029

Nicotine toxicity acting on cardiac neurons	1997 (Cycle VI)	$446,920
University of California, San Diego	Darwin Berg Ph.D.	6RT-0050

Nicotine withdrawal, smoking & attention: an fMRI study	2001 (Cycle X)	$515,303
University of California, Los Angeles	Edythe London Ph.D.	10RT-0091H

Nicotine-dependent recruitment of vascular progenitor cells	2006 (Cycle XV)	$799,907
The Burnham Institute for Medical Research	William Stallcup Ph.D.	15RT-0034

Nicotine-pathological angiogenesis and genetic determinants	2002 (Cycle XI)	$608,420
Stanford University	John Cooke M.D., Ph.D.	11RT-0147

Nicotine's effects on uterine artery contractillity	2005 (Cycle XIV)	$73,878
Loma Linda University	DaLiao Xiao Ph.D.	14FT-0075

Nicotinic and Schizophrenia	2000 (Cycle IX)	$87,719
University of California, Irvine	Ricardo Miledi M.D.	9RT-0173

Nicotinic Manipulation of the Hippocampus	2007 (Cycle XVI)	$420,000
University of California, San Diego	Darwin Berg Ph.D.	16RT-0167

Nicotinic modulation of dopamine release during development	1999 (Cycle VIII)	$25,698
University of California, Irvine	Layla Azam	8DT-0168

Nicotinic receptors & synaptic aging	2001 (Cycle X)	$224,973
University of California, San Diego	Jay Coggan Ph.D.	10KT-0082

Nicotinic receptors and Parkinson's disease	2002 (Cycle XI)	$376,470
The Parkinson's Institute	Maryka Quik Ph.D.	11RT-0216

Nicotinic receptors at GABAergic synapses in the hippocampus	2004 (Cycle XIII)	$75,000
University of California, San Diego	Jingming Zhang Ph.D.	13FT-0005

Nicotinic receptors in nicotine addiction	2008 (Cycle XVII)	$634,779
California Institute of Technology	Henry Lester Ph.D.	17RT-0127

Nicotinic receptors on hippocampal neurons	2002 (Cycle XI)	$69,940
University of California, San Diego	Wagner Zago Ph.D.	11FT-0099

Nicotinic receptors, smoking and Parkinson's Disease	2002 (Cycle XI)	$765,971
Stanford University	Lorene Nelson Ph.D.	11RT-0237

Nicotinic Regulation of GABAergic Inhibition/Excitation	2008 (Cycle XVII)	$75,000
University of California, San Diego	Natalia Gounko Ph.D.	17FT-0053

Nicotinic Regulation of GABAergic Signaling	2006 (Cycle XV)	$70,120
University of California, San Diego	Zhaoping Liu Ph.D.	15KT-0157

Nicotinic Regulation of Neurogenesis in Adult Hippocampus	2008 (Cycle XVII)	$60,000
University of California, San Diego	Nolan Campbell B.S. Biology	17DT-0191

Nicotonic receptors: role in addiction and reproduction	1997 (Cycle VI)	$437,480
Salk Institute for Biological Studies	Stephen Heinemann Ph.D.	6RT-0055

Nitric oxide-dependent cell signaling in vascular cells	2000 (Cycle IX)	$149,557
University of California, San Diego	Tanima Gudi Ph.D.	9KT-0170H

Nitrogen Oxides and cigarette smoke-induced injury	1998 (Cycle VII)	$304,118
University of California, Davis	Albert van der Vliet Ph.D.	7RT-0167

NMR studies of the LDL receptor active conformation of ApoE	2007 (Cycle XVI)	$60,000
University of California, Berkeley	Paul Hauser B.S.	16DT-0195

NMR Study of 13C Edatrexate Metabolism	1995 (Cycle IV)	$258,990
University of California, Davis	Thomas Jue Ph.D.	4RT-0373

Noninvasive imaging of early atherosclerosis	1997 (Cycle VI)	$101,923
University of California, San Diego	Sotirios Tsimikas M.D.	6KT-0100

Nonsmokers helping smokers and the role of culture	2004 (Cycle XIII)	$476,656
University of California, San Diego	Shu-Hong Zhu Ph.D.	13RT-0023

Novel agents for apoptosis of lung cancer	2002 (Cycle XI)	$787,977
The Burnham Institute for Medical Research	Xiao-Kun Zhang Ph.D.	11RT-0081

Novel Approaches to Lung Cancer Research	2006 (Cycle XV)	$189,486
The Burnham Institute for Medical Research	Kristiina Vuori M.D., Ph.D.	15IT-0021

Novel Cationic Polymers for RNAi Delivery in NSCLC Treatment	2007 (Cycle XVI)	$75,000
University of California, Irvine	Lai Chu Lin Ph.D.	16FT-0058

Novel DNA vaccines for the treatment of lung cancer	2000 (Cycle IX)	$1,063,300
Scripps Research Institute	Ralph Reisfeld Ph.D.	9RT-0017

Novel DNA vaccines for the treatment of lung cancer	2003 (Cycle XII)	$783,900
Scripps Research Institute	Ralph Reisfeld Ph.D.	12RT-0002

Novel Extracellular Sulfatases and Smoke-induced Lung Cancer	2008 (Cycle XVII)	$394,380
University of California, San Francisco	Steven Rosen Ph.D.	17RT-0117

Novel imaging methods for diagnosing tobacco related cancers	1997 (Cycle VI)	$629,087
Stanford University	Albert Macovski Ph.D.	6RT-0384

Novel nicotine cessation therapeutics	2000 (Cycle IX)	$802,840
Human BioMolecular Research Institute	John Cashman Ph.D.	9RT-0196H

Novel Office-Based Device for Imaging Vocal Cord Cancer	2003 (Cycle XII)	$510,000
University of California, Irvine	Brian Wong M.D., Ph.D.	12RT-0113

Novel regulatory mechanisms for lung cancer growth	2000 (Cycle IX)	$100,000
University of California, San Diego	Randolph Hastings M.D., Ph.D.	9RT-0037

Novel regulatory mechanisms for lung cancer growth	2001 (Cycle X)	$620,032
Veterans Medical Research Foundation	Randolph Hastings M.D., Ph.D.	10RT-0161H

Novel strategy for protecting neurons from injury in stroke	1999 (Cycle VIII)	$742,809
Stanford University	Robert Sapolsky Ph.D.	8RT-0073

Novel therapy for pancreatic cancer	1997 (Cycle VI)	$452,332
University of California, Irvine	Hung Fan Ph.D.	6RT-0266

NRT and paroxetine for smoking cessation	1997 (Cycle VI)	$646,916
Stanford University	Joel Killen Ph.D.	6RT-0041

Oral clefts, smoking & variation of toxin biotransformation	2004 (Cycle XIII)	$623,472
Children's Hospital Oakland Research Institute	Edward Lammer M.D.	13RT-0109

Oral clefts, smoking & variation toxin biotransformation	1997 (Cycle VI)	$677,128
Children's Hospital Oakland Research Institute	Edward Lammer M.D.	6RT-0360

Overcoming drug resistance in small cell lung cancer	2001 (Cycle X)	$141,340
The Burnham Institute for Medical Research	Kristiina Vuori M.D., Ph.D.	10IT-0246

Oxidative damage to sperm DNA: smoking and diet interaction	1998 (Cycle VII)	$155,135
University of California, Berkeley	Bruce Ames Ph.D.	7RT-0178

Oxidative damage to sperm DNA: smoking and diet interaction	1998 (Cycle VII)	$132,367
Children's Hospital Oakland Research Institute	Bruce Ames Ph.D.	7RT-0178A

Oxidative stress and skeletal muscle dysfunction in COPD	2006 (Cycle XV)	$555,000
University of California, San Diego	Russell Richardson Ph.D.	15RT-0100H

Oxidized lipids and programmed cell death in atherosclerosis	1999 (Cycle VIII)	$69,116
University of California, San Diego	Mi-Kyung Chang M.D.	8FT-0101

Oxygen Club of California	2007 (Cycle XVI)	$5,000
Oxygen Club	John Maguire DDS	16ST-0218

Oxygen Club of California	2003 (Cycle XII)	$5,000
Oxygen Club	John Maguire DDS	12ST-0267

Oxygen Club of California	2005 (Cycle XIV)	$5,000
Oxygen Club	John Maguire DDS	14ST-0193

Oxygen radicals in biology GRC 2006	2005 (Cycle XIV)	$5,000
University of California, Merced	Henry Forman Ph.D.	14ST-0191

Oxygen Radicals in Biology GRC2008	2007 (Cycle XVI)	$5,000
University of Southern California	Enrique Cadenas Ph.D.	16ST-0216

Oxygen Transport Following Lung Transplantation in COPD	2007 (Cycle XVI)	$74,500
University of California, San Diego	Moh Malek Ph.D.	16FT-0060

Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation	2007 (Cycle XVI)	$260,203
University of California, Davis	Ayala Luria Ph.D.	16KT-0037

p53 and p14ARF: Multiple pathways of lung cancer suppression	2002 (Cycle XI)	$821,050
Sidney Kimmel Cancer Center	Ruth Gjerset Ph.D.	11RT-0074

p53 Mutations in Sporadic & Familial Childhood Tumors	1994 (Cycle III)	$213,407
University of California, Davis	Sara Bodner M.D.	3KT-0400A

Pager-assisted smoking cessation treatment	2002 (Cycle XI)	$463,689
University of California, San Francisco	Timothy Carmody Ph.D.	11RT-0009

Pager-cued therapeutic messages for smoking cessation	1999 (Cycle VIII)	$74,889
University of California, San Francisco	Timothy Carmody Ph.D.	8IT-0053A

Parental and Movie Influences on Adolescent Smoking Behavior	1999 (Cycle VIII)	$50,793
University of California, San Diego	Janet Distefan Ph.D.	8DT-0167

Parkinson's Disease: A Protective Effect of Smoking?	1999 (Cycle VIII)	$512,849
Stanford University	Lorene Nelson Ph.D.	8RT-0131